Related Experiment Video
Updated: Jun 12, 2026

Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
Published on: February 24, 2023
Macrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis
1Department of Pediatrics, Maulana Azad Medical College, University of Delhi, New Delhi, India. drmonicajuneja@gmail.com
Abstract:
Macrophage activation syndrome is a rare and potentially life threatening complication of childhood rheumatic disorders. It is described most commonly with systemic onset juvenile idiopathic arthritis (soJIA). The major clinical manifestations are non-remitting fever, hepatosplenomegaly, lymphadenopathy, bleeding diathesis, altered mental status and rash and may mimic a fl are of soJIA. The characteristic laboratory findings are leucopenia, thrombocytopenia and dramatic elevation of urinary beta2 microglobulin. Corticosteroids and cyclosporine are the drugs commonly used in its management. Early diagnosis and prompt treatment can be life saving. We report a case of 12 year old female child with inadequately treated systemic onset juvenile idiopathic arthritis who developed fatal macrophage activation syndrome. The diagnosis and management of macrophage activation syndrome are discussed.
Insights
Macrophage activation syndrome (MAS) is a severe complication of juvenile idiopathic arthritis. Early diagnosis and treatment are crucial for survival, as illustrated by a fatal case in a 12-year-old girl.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Hematology
Background:
- Macrophage activation syndrome (MAS) is a rare, life-threatening complication of childhood rheumatic disorders, most commonly systemic onset juvenile idiopathic arthritis (soJIA).
- MAS presents with non-remitting fever, hepatosplenomegaly, lymphadenopathy, bleeding, altered mental status, and rash, mimicking soJIA flares.
- Key laboratory findings include leucopenia, thrombocytopenia, and elevated urinary beta2 microglobulin.
Observation:
- This report details a fatal case of MAS in a 12-year-old female with inadequately treated systemic onset juvenile idiopathic arthritis.
- The patient exhibited typical clinical and laboratory features suggestive of MAS.
Findings:
- The case highlights the critical need for vigilant monitoring in patients with soJIA.
- Prompt and accurate diagnosis of MAS is essential for effective management.
Implications:
- Early recognition and intervention in MAS can be life-saving.
- This case underscores the importance of aggressive management strategies for MAS in pediatric rheumatic diseases.
- Further research into optimal treatment protocols for MAS is warranted.
Related Concept Videos
Chronic Inflammation: Introduction
The JAK-STAT Signaling Pathway
Acute Inflammation III: Local and Systemic Effects
Acute Inflammation II: Cellular Phase
Rheumatic Heart Disease I: Introduction
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...